223 related articles for article (PubMed ID: 31686862)
1. Upregulation Of Protein Tyrosine Phosphatase Receptor Type C Associates To The Combination Of Hashimoto's Thyroiditis And Papillary Thyroid Carcinoma And Is Predictive Of A Poor Prognosis.
Wu Y; Han J; Vladimirovna KE; Zhang S; Lv W; Zhang Y; Jamaspishvili E; Sun J; Fang Q; Meng J; Qiao H
Onco Targets Ther; 2019; 12():8479-8489. PubMed ID: 31686862
[TBL] [Abstract][Full Text] [Related]
2. Identifying and analyzing the key genes shared by papillary thyroid carcinoma and Hashimoto's thyroiditis using bioinformatics methods.
Liu TT; Yin DT; Wang N; Li N; Dong G; Peng MF
Front Endocrinol (Lausanne); 2023; 14():1140094. PubMed ID: 37324256
[TBL] [Abstract][Full Text] [Related]
3. Significance of DMBT1 in Papillary Thyroid Carcinoma Concurrent With Hashimoto's Thyroiditis.
Gan XX; Li YY; Li SJ; Mo SS; Feng JH; Shen F; Cai WS; Lai YQ; Xu B
Front Oncol; 2021; 11():680873. PubMed ID: 34422633
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis identified shared differentially expressed genes as potential biomarkers for Hashimoto's thyroiditis-related papillary thyroid cancer.
Liu C; Pan Y; Li Q; Zhang Y
Int J Med Sci; 2021; 18(15):3478-3487. PubMed ID: 34522174
[No Abstract] [Full Text] [Related]
5. Identification of
Zhang Y; Xie X; Zhou H; Li B; Ding L; Cai Z; Song H; Zhao S; Xu H
Front Endocrinol (Lausanne); 2023; 14():1131078. PubMed ID: 37455914
[TBL] [Abstract][Full Text] [Related]
6. Soluble DPP4 can act as a diagnostic biomarker in Hashimoto's thyroiditis with thyroid papillary carcinoma.
Zhang Y; Zhang Q; Zheng Y; Chen J; Liu N; Liu K; Song W
J Cancer Res Ther; 2023 Aug; 19(4):1048-1054. PubMed ID: 37675735
[TBL] [Abstract][Full Text] [Related]
7. Hashimoto's Thyroiditis and Papillary Cancer Thyroid Coexistence Exerts a Protective Effect: a Single Centre Experience.
Battistella E; Pomba L; Costantini A; Scapinello A; Toniato A
Indian J Surg Oncol; 2022 Mar; 13(1):164-168. PubMed ID: 35462652
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
9. Mutation of Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes.
Zhang L; Zhou L; Feng Q; Li Q; Ge M
Front Oncol; 2021; 11():813802. PubMed ID: 34993154
[TBL] [Abstract][Full Text] [Related]
10. Hashimoto's Thyroiditis Effects on Papillary Thyroid Carcinoma Outcomes: A Systematic Review.
Osborne D; Choudhary R; Vyas A; Kampa P; Abbas LF; Chigurupati HD; Alfonso M
Cureus; 2022 Aug; 14(8):e28054. PubMed ID: 36120263
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of lncRNA-mediated ceRNA regulatory networks and key genes associated with papillary thyroid cancer coexistent with Hashimoto's thyroiditis.
Zhang Y; Tian Y
BMC Endocr Disord; 2022 Oct; 22(1):252. PubMed ID: 36266640
[TBL] [Abstract][Full Text] [Related]
12. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
13. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
14. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
16. Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.
Sur ML; Gaga R; Lazăr C; Lazea C; Aldea C; Sur D
J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1511-1517. PubMed ID: 33180046
[TBL] [Abstract][Full Text] [Related]
17. Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto's Thyroiditis.
Zhang Y; Lu KN; Ding JW; Peng Y; Pan G; Teng LS; Luo DC
Front Oncol; 2022; 12():766016. PubMed ID: 35359359
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonographic, clinical, and pathological features of papillary thyroid carcinoma in children and adolescents with or without Hashimoto's thyroiditis.
Jie Y; Ruan J; Luo M; Liu R
Front Oncol; 2023; 13():1198468. PubMed ID: 37593099
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
[TBL] [Abstract][Full Text] [Related]
20. P2X7 Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis.
Kwon JH; Nam ES; Shin HS; Cho SJ; Park HR; Kwon MJ
Korean J Pathol; 2014 Feb; 48(1):30-5. PubMed ID: 24627692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
